A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
Prescient Therapeutics, Ltd.
Memorial Sloan Kettering Cancer Center
Washington University School of Medicine
UNC Lineberger Comprehensive Cancer Center
National Cancer Institute (NCI)
City of Hope Medical Center
Assistance Publique - Hôpitaux de Paris
Kyowa Kirin Co., Ltd.
SciTech Development, Inc.
City of Hope Medical Center
Mayo Clinic
Icahn School of Medicine at Mount Sinai
Barbara Ann Karmanos Cancer Institute
Stanford University
City of Hope Medical Center
Thomas Jefferson University
Washington University School of Medicine
Ohio State University Comprehensive Cancer Center
University College, London
Innate Pharma
4SC AG
Emory University
Kyowa Kirin Co., Ltd.
Northwestern University
City of Hope Medical Center
European Organisation for Research and Treatment of Cancer - EORTC
Wake Forest University Health Sciences
Stanford University
Stanford University
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
University of Nebraska
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Genmab
Stanford University
Genmab
Atara Biotherapeutics
National Institutes of Health Clinical Center (CC)
Elorac, Inc.
National Institutes of Health Clinical Center (CC)
Mayo Clinic
Memorial Sloan Kettering Cancer Center
4SC AG
Northwestern University
European Organisation for Research and Treatment of Cancer - EORTC